Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.55 Analyst target: $3.50 Upside: 538.10%
MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company. The company is headquartered in Baltimore, Maryland.
See the full interactive analysis & chart →Informational only — not investment advice.